Thursday, July 20, 2023 9:56:53 AM
Recent TTOO News
- T2 Biosystems Announces Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 11/14/2024 09:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 08:49:19 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/14/2024 08:38:45 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/08/2024 10:00:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2024 02:30:28 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/07/2024 02:02:19 AM
- T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024 • GlobeNewswire Inc. • 11/05/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 08:59:59 PM
- T2 Biosystems to Host Business Update Call on October 10, 2024 • GlobeNewswire Inc. • 10/08/2024 08:05:00 PM
- T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform • GlobeNewswire Inc. • 10/08/2024 01:00:00 PM
- T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens • GlobeNewswire Inc. • 10/07/2024 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2024 01:00:32 PM
- T2 Biosystems Announces Preliminary Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 10/07/2024 01:00:00 PM
- T2 Biosystems Highlights New Article Published in The Lancet: Changing the Culture of Blood Culture • GlobeNewswire Inc. • 09/23/2024 01:00:00 PM
- T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union • GlobeNewswire Inc. • 09/20/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 12:59:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 01:16:29 PM
- T2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric Patients • GlobeNewswire Inc. • 09/16/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 01:10:01 PM
- T2 Biosystems Provides Updates on its New Product Development Pipeline Progress • GlobeNewswire Inc. • 09/09/2024 01:00:00 PM
- T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 08/27/2024 08:05:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/23/2024 08:31:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:49:41 PM
- T2 Biosystems to Attend Upcoming Investor Conferences • GlobeNewswire Inc. • 08/01/2024 08:05:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/30/2024 04:15:10 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM